azathioprine has been researched along with Myositis, Inclusion Body in 6 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Myositis, Inclusion Body: Progressive myopathies characterized by the presence of inclusion bodies on muscle biopsy. Sporadic and hereditary forms have been described. The sporadic form is an acquired, adult-onset inflammatory vacuolar myopathy affecting proximal and distal muscles. Familial forms usually begin in childhood and lack inflammatory changes. Both forms feature intracytoplasmic and intranuclear inclusions in muscle tissue. (Adams et al., Principles of Neurology, 6th ed, pp1409-10)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 66-year-old woman with a history of interstitial lung disease presented with a 3-month history of dropped head syndrome (DHS), followed by camptocormia and extremity weakness." | 1.48 | Dropped Head Syndrome and the Presence of Rimmed Vacuoles in a Muscle Biopsy in Scleroderma-polymyositis Overlap Syndrome Associated with Anti-Ku Antibody. ( Higuchi, I; Jonosono, M; Mitsuyo, K; Yoshida, M; Yoshida, T, 2018) |
| "The sporadic inclusion body myositis weakness composite index, which correlated with grip strength (correlation coefficient: 0." | 1.37 | Long-term observational study of sporadic inclusion body myositis. ( Allenbach, Y; Benveniste, O; Brady, S; Dubourg, O; Eymard, B; Freebody, J; Guiguet, M; Herson, S; Hilton-Jones, D; Leite, MI; Maisonobe, T; Squier, W; Stojkovic, T, 2011) |
| "Although most patients with inclusion body myositis have characteristic muscle biopsy findings, some cannot be distinguished histologically early from polymyositis." | 1.29 | Inclusion body myositis: clinical and pathological boundaries. ( Amato, AA; Barohn, RJ; Bryan, WW; Gronseth, GS; Jackson, CE; Katz, JS; Wolfe, GI, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Limaye, VS | 1 |
| Cash, K | 1 |
| Smith, C | 1 |
| Koszyca, B | 1 |
| Patel, S | 1 |
| Greenberg, SA | 1 |
| Hissaria, P | 1 |
| Yoshida, T | 1 |
| Yoshida, M | 1 |
| Mitsuyo, K | 1 |
| Jonosono, M | 1 |
| Higuchi, I | 1 |
| Recher, M | 1 |
| Sahrbacher, U | 1 |
| Bremer, J | 1 |
| Arndt, B | 1 |
| Steiner, U | 1 |
| Fontana, A | 1 |
| Benveniste, O | 1 |
| Guiguet, M | 1 |
| Freebody, J | 1 |
| Dubourg, O | 1 |
| Squier, W | 1 |
| Maisonobe, T | 1 |
| Stojkovic, T | 1 |
| Leite, MI | 1 |
| Allenbach, Y | 1 |
| Herson, S | 1 |
| Brady, S | 1 |
| Eymard, B | 1 |
| Hilton-Jones, D | 1 |
| Amato, AA | 1 |
| Gronseth, GS | 1 |
| Jackson, CE | 1 |
| Wolfe, GI | 1 |
| Katz, JS | 1 |
| Bryan, WW | 1 |
| Barohn, RJ | 1 |
| Gause, A | 1 |
| Inderrieden, DC | 1 |
| Laas, R | 1 |
| Arlt, AC | 1 |
| Gross, WL | 1 |
6 other studies available for azathioprine and Myositis, Inclusion Body
| Article | Year |
|---|---|
Inclusion-body myositis and primary Sjögren syndrome: mechanisms for shared etiologies.
Topics: 5'-Nucleotidase; Adult; Autoantibodies; Azathioprine; CD8-Positive T-Lymphocytes; Female; Haplotypes | 2020 |
Dropped Head Syndrome and the Presence of Rimmed Vacuoles in a Muscle Biopsy in Scleroderma-polymyositis Overlap Syndrome Associated with Anti-Ku Antibody.
Topics: Aged; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Female; Head Movements; Humans; Immuno | 2018 |
Treatment of inclusion body myositis: is low-dose intravenous immunoglobulin the solution?
Topics: Adrenal Cortex Hormones; Aged; Azathioprine; Drug Resistance; Female; Humans; Immunoglobulins, Intra | 2012 |
Long-term observational study of sporadic inclusion body myositis.
Topics: Aged; Azathioprine; Cohort Studies; Disability Evaluation; Female; Humans; Immunoglobulins, Intraven | 2011 |
Inclusion body myositis: clinical and pathological boundaries.
Topics: Aged; Azathioprine; Biopsy; Creatine Kinase; Dermatomyositis; Diagnosis, Differential; Female; Human | 1996 |
Common variable immunodeficiency (CVID) and inclusion body myositis (IBM).
Topics: Adult; Arthralgia; Azathioprine; Common Variable Immunodeficiency; Fatigue; gamma-Globulins; Humans; | 2000 |